AMERICAN CENTURY COMPANIES INC

Position in ALLO — Allogene Therapeutics, Inc.

CIK 748054 KANSAS CITY, MO

Position in ALLO

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$431,400

+$308,844 QoQ

Shares Held

207,404

+312.9% QoQ

Ownership

0.060%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#80

of 209 holders

Holding Since

Sep 2022

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

AMERICAN CENTURY COMPANIES INC holds $3,618,743,392 across 179 Biotechnology names. ALLO ranks #126 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	1,853,956	$558,096,374
2	ASND	Ascendis Pharma A/S	1,400,575	$373,561,364
3	VRTX	Vertex Pharmaceuticals Inc / Ma	580,901	$288,550,953
4	ARGX	Argenx SE	173,193	$160,683,269
5	IONS	Ionis Pharmaceuticals Inc	1,947,076	$154,383,656
6	EXEL	Exelixis, Inc.	1,791,664	$97,484,438
7	HRMY	Harmony Biosciences Holdings, Inc.	2,539,512	$92,463,631
8	GPCR	Structure Therapeutics Inc.	1,682,179	$90,282,546

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$431,400	207,404	+312.9%	Shares	Defined	2026-08-12
2026-03-31	$122,556	50,228	-78.4%	Shares	Defined	2026-05-15
2024-12-31	$494,918	232,356	+16.5%	Shares	Defined	2025-02-11
2024-09-30	$558,378	199,421	+21.9%	Shares	Defined	2024-11-12
2024-06-30	$381,045	163,539	+31.8%	Shares	Defined	2024-08-07
2024-03-31	$554,463	124,041	+58.7%	Shares	Defined	2024-05-14
2023-12-31	$250,851	78,147	+40.7%	Shares	Defined	2024-02-13
2023-09-30	$176,049	55,536	+28.7%	Shares	Defined	2023-11-13
2023-06-30	$214,485	43,156	+62.9%	Shares	Defined	2023-08-14
2023-03-31	$130,870	26,492	+20.3%	Shares	Defined	2023-05-11
2022-12-31	$138,537	22,025	+29.6%	Shares	Defined	2023-02-13
2022-09-30	$183,567	16,997	—	Shares	Defined	2022-11-14
No filing history on record for this holder in this stock.